Rheumatoid factor as predictor of response to treatment with anti-TNF alpha drugs in patients with rheumatoid arthritis

We determined whether rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibody (ACPA) can predict remission or severe disability in rheumatoid arthritis (RA) patients treated with anti-tumor necrosis factor (TNF) alpha drugs. We performed a cohort study based on the clinical data from a...

Full description

Autores:

Santos Moreno, Pedro
Sánchez, Guillermo
Castro, Carlos

Tipo de recurso:

Article of journal

Fecha de publicación:

2019

Institución:

Fundación Universitaria de Ciencias de la Salud - FUCS

Repositorio:

Repositorio Digital Institucional ReDi

Idioma:

eng

OAI Identifier:

oai:repositorio.fucsalud.edu.co:001/1990

Acceso en línea:

https://repositorio.fucsalud.edu.co/handle/001/1990

Palabra clave:

Discapacidad
Anti-cyclic citrullinated peptide antibodies
Disability
Remission
Rheumatoid arthritis
Rheumatoid factor
Factor reumatoide
Artritis reumatoide
Remisión
Anticuerpos antiproteína citrulinada

Rights

openAccess

License

Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)